These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38504462)

  • 61. Folate with methotrexate: big benefit, questionable cost.
    Brownell I; Strober BE
    Br J Dermatol; 2007 Jul; 157(1):213. PubMed ID: 17578449
    [No Abstract]   [Full Text] [Related]  

  • 62. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.
    Rosenberg P; Urwitz H; Johannesson A; Ros AM; Lindholm J; Kinnman N; Hultcrantz R
    J Hepatol; 2007 Jun; 46(6):1111-8. PubMed ID: 17399848
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Methotrexate: understanding the risk in psoriasis patients.
    Lucas J; Ntuen E; Pearce DJ; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2009; 20(5):311-3. PubMed ID: 19363738
    [No Abstract]   [Full Text] [Related]  

  • 64. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B; Saraswat A; Kaur I
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Toxic epidermal necrosis-like dermatosis induced by the first course of methotrexate.
    Sawada Y; Kawakami C; Nakamura M; Tokura Y; Yoshiki R
    Eur J Dermatol; 2009; 19(4):397-8. PubMed ID: 19467968
    [No Abstract]   [Full Text] [Related]  

  • 66. Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate.
    Farhangian ME; Feldman SR
    Am J Clin Dermatol; 2015 Aug; 16(4):285-294. PubMed ID: 25963062
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methotrexate for psoriasis.
    Boffa MJ; Chalmers RJ
    Clin Exp Dermatol; 1996 Nov; 21(6):399-408. PubMed ID: 9167333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Conventional therapies for psoriasis.
    Rebora A
    Reumatismo; 2007; 59 Suppl 1():77-80. PubMed ID: 17828351
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
    Langman G; Hall PM; Todd G
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.
    Berends MA; van Oijen MG; Snoek J; van de Kerkhof PC; Drenth JP; Han van Krieken J; de Jong EM
    Arch Dermatol; 2007 Dec; 143(12):1515-9. PubMed ID: 18087000
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
    Berends MA; Snoek J; de Jong EM; van de Kerkhof PC; van Oijen MG; van Krieken JH; Drenth JP
    Aliment Pharmacol Ther; 2006 Sep; 24(5):805-11. PubMed ID: 16918884
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The use of self-administered subcutaneous methotrexate for the treatment of psoriasis.
    Chiaravalloti AJ; Strober BE
    J Drugs Dermatol; 2014 Aug; 13(8):929-31. PubMed ID: 25116970
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rapidly fatal acute ATLL emerging after methotrexate therapy for disseminated psoriasis.
    Dasanu CA; Bauer F; Ichim TE; Vyas D; Ek K; Alexandrescu DT
    Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):76-8. PubMed ID: 21729685
    [No Abstract]   [Full Text] [Related]  

  • 74. A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy.
    Savoia F; Gaddoni G; Casadio C; Patrizi A; Spadola G; Bassi P; Albertini F; Ballardini G; Briganti E; Casolari S; De Donà D; Menni B; Zanotti M; De Angelis P
    Dermatol Online J; 2010 Feb; 16(2):13. PubMed ID: 20178709
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine.
    Warren RB; Griffiths CE
    Clin Dermatol; 2008; 26(5):438-47. PubMed ID: 18755362
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Daily practice assessment of liver injury in patients with psoriasis on methotrexate.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2010 Jan; 162(1):211-3. PubMed ID: 19903179
    [No Abstract]   [Full Text] [Related]  

  • 79. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
    Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
    Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Methotrexate toxicity induced by ciprofloxacin leading to psoriatic plaque ulceration: a case report.
    Kamangar F; Berger TG; Fazel N; Koo JY
    Cutis; 2013 Sep; 92(3):148-50. PubMed ID: 24153144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.